ABSTRACT
Transient osteoporosis of hip is an uncommon, self-limiting clinical condition of unknown etiology characterized by an acute onset of hip pain, an antalgic gait and limited ranges of motion. Frequently this is followed by spontaneous regression of the symptoms within a few months (6 to 8 months), therefore conservative treatment is the best therapeutic strategy. Surgical decompression are performed only for the conservative therapy resistant patients. In this report, it is presented a 32-years old female who had pregnancy-associated transient osteoporosis and showed satisfactory improvement with conservative treatment via adding vitamin K2. Vitamin K2 may be considered as a treatment option before surgical intervention in the patients with transient osteoporosis of the hip who did not adequately respond to previously described conservative treatment modalities.
References
1
Guerra JJ, Steinberg ME. Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am 1995;77:616-24.
2
Bijl M, van Leeuwen MA, van Rijswijk MH. Transient osteoporosis of the hip: presentation of (a) typical cases and a review of the literature. Clin Exp Rheumatol 1999;17:601-4.
3
Ma FY, Falkenberg M. Case reports: transient osteoporosis of the hip: an atypical case. Clin Orthop Relat Res 2006;445:245-9.
4
Axt-Fliedner R, Schneider G, Seil R, Friedrich M, Mink D, Schmidt W. Transient bilateral osteoporosis of the hip in pregnancy. A case report and review of the literature. Gynecol Obstet Invest 2001;51:138-40.
5
Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum 2003;32:388-97.
6
Ergun T, Lakadamyali H. The relationship between MRI findings and duration of symptoms in transient osteoporosis of the hip. Acta Orthop Traumatol Turc 2008;42:10-5.
7
Erdem HR, Ozdemirel AE, Nacır B, et al. Idiopathic Transient Osteoporosis of the Hip in a Non-Pregnant Woman: A Case Report. Turk J Phys Med Rehab 2013;59:157-60.
8
Hadidy AM, Al Ryalat NT, Hadidi ST, Tarawneh ES, Hadidi MT, Samara OA, et al. Male transient hip osteoporosis: are physicians at a higher risk? Arch Osteoporos 2009;4:41-5.
9
Klontzas ME, Vassalou EE, Zibis AH, Bintoudi AS, Karantanas AH. MR imaging of transient osteoporosis of the hip: an update on 155 hip joints. Eur J Radiol 2015;84:431-6.
10
Hofmann S, Engel A, Neuhold A, Keder K, Kramer J, Plenk Jr H. Bone-marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg Br 1993;75:210-6.
11
Niimi R, Sudo A, Hasegawa M, Fukuda A, Uchida A. Changes in bone mineral density in transient osteoporosis of the hip. J Bone Joint Surgery Br 2006;88:1438-40.
12
McCord WC, Nies KM, Campion DS, Louie JS. Regional migratory osteoporosis: A denervation disease. Arthr Rheum 1978;21:834-8.
13
Asadipooya K, Graves L, Greene LW. Transient osteoporosis of the hip: review of the literature. Osteoporos Int 2017;8:1805-16.
14
Kibbi L, Touma Z, Khoury N, Arayssi T. Oral bisphosphonates in treatment of transient osteoporosis. Clin Rheumatol 2008;27:529-32.
15
Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum 2003;32:388-97.
16
Naito Y, Wakabayashi H, Kato S, Nakagawa T, Iino T, Sudo A, et al. Alendronate inhibits hyperalgesia and suppresses neuropeptide markers of pain in a mouse model of osteoporosis. J Orthop Sci 2017;22:771-7.
17
Winarno AS, Kyvernitakis I, Hadji P. Successful treatment of 1-34 parathyroid hormone (PTH) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtshilfe Neonatol 2014;218:171-3.
18
Fusaro M, Mereu MC, Aghi A, Iervasi G, Gallieni M. Vitamin K and bone. Clin Cases Miner Bone Metab 2017;14:200-6.
19
Inaba N, Sato T, Yamashita T. Low-dose Daily intake of vitamin K2 (Menaquinone-7) improves osteocalsin-g-carboxylation: a double-blind, randomized controlled trials. J Nutr Sci Vitaminol 2015;61:471-80.
20
Tsuchie H, Miyakoshi N, Hongo M, Kasukawa Y, Ishikawa Y, Shimada Y. Amelioration of pregnancy-associated osteoporosis after treatment with vitamin K2: a report of four patients. Ups J Med Sci 2012;117:336-41.
21
Nakamura Y, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, et al. A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature. Ther Clin Risk Mana 2015;11:1361-5.